Cognition Therapeutics, Inc. (CGTX)
NASDAQ$0.4469
Market Cap
$18.57M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
357 of 924
Rank in Industry
209 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
CGTX Insider Trading Activity
CGTX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $30,001 | 1 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Ricciardi Lisa | CEO & President | 1 | $30,001 | 0 | $0 | $30,001 |
About Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical trial for the treatment of mild-to-moderate Alzheimer's disease, as well as has completed Phase I clinical trial to treat early-stage Alzheimer's disease; in Phase II clinical trial for the treatment of …
Insider Activity of Cognition Therapeutics, Inc.
Over the last 12 months, insiders at Cognition Therapeutics, Inc. have bought $30,001 and sold $0 worth of Cognition Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Cognition Therapeutics, Inc. have bought $2.82M and sold $4,818 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Ricciardi Lisa (CEO & President) — $30,001.
The last purchase of 38,851 shares for transaction amount of $30,001 was made by Ricciardi Lisa (CEO & President) on 2025‑01‑31.
List of Insider Buy and Sell Transactions, Cognition Therapeutics, Inc.
| 2025-01-31 | Ricciardi Lisa | CEO & President | 38,851 0.094% | $0.77 | $30,001 | -21.98% | ||
| 2024-03-14 | Ricciardi Lisa | CEO & President | 5,700 0.0172% | $1.75 | $9,975 | -60.21% | ||
| 2022-11-29 | RICHSTONE ELLEN B | director | 10,000 0.0453% | $2.65 | $26,550 | -29.84% | ||
| 2022-11-28 | Kreis Leslie W. | director | 16,064 0.0706% | $2.65 | $42,565 | -31.76% | ||
| 2022-11-28 | Fletcher Aaron G.L. | director | 16,064 0.0706% | $2.65 | $42,565 | -31.76% | ||
| 2022-11-16 | Kreis Leslie W. | director | 71,000 0.3069% | $1.40 | $99,400 | +27.74% | ||
| 2022-11-16 | Fletcher Aaron G.L. | director | 71,000 0.3069% | $1.40 | $99,400 | +27.74% | ||
| 2022-11-15 | Kreis Leslie W. | director | 1.5M 5.2511% | $1.20 | $1.8M | +20.69% | ||
| 2022-11-15 | Fletcher Aaron G.L. | director | 1.5M 5.2511% | $1.20 | $1.8M | +20.69% | ||
| 2022-11-15 | Wallace Peggy | director | 12,500 0.0438% | $1.20 | $15,000 | +20.69% | ||
| 2022-11-15 | Ricciardi Lisa | CEO & President | 12,000 0.0455% | $1.30 | $15,600 | +20.69% | ||
| 2021-10-13 | Sale | Ogden CAP Associates, LLC | 10 percent owner | 74.05 0.0014% | $12.00 | $889 | -76.39% | |
| 2021-10-13 | Sale | Golden Seeds Cognition Therapeutics LLC | 10 percent owner | 33.09 0.0006% | $12.00 | $397 | -76.39% | |
| 2021-10-13 | Sale | Breedlove Mark H. | director | 23.48 0.0004% | $12.00 | $282 | -76.39% | |
| 2021-10-13 | Sale | Fletcher Aaron G.L. | director | 180.56 0.0034% | $12.00 | $2,167 | -76.39% | |
| 2021-10-13 | Sale | BIOS Memory SPV I, LP | 10 percent owner | 90.28 0.0017% | $12.00 | $1,083 | -76.39% | |
| 2021-10-13 | Fletcher Aaron G.L. | director | 380,000 7.2005% | $12.00 | $4.56M | -76.39% | ||
| 2021-10-13 | BIOS Memory SPV I, LP | 10 percent owner | 190,000 3.6003% | $12.00 | $2.28M | -76.39% | ||
| 2021-10-13 | Ricciardi Lisa | CEO & President | 25,000 0.4737% | $12.00 | $300,000 | -76.39% | ||
| 2021-10-13 | O'Brien James Michael | Chief Financial Officer | 10,000 0.1895% | $12.00 | $120,000 | -76.39% |
Total: 21
*Gray background shows transactions not older than one year
Insider Historical Profitability
<0.0001%
| Ricciardi Lisa | CEO & President | 38851 0.0935% | $17,362.51 | 4 | 0 | <0.0001% |
| Fletcher Aaron G.L. | director | 2021906 4.8664% | $903,589.79 | 4 | 1 | <0.0001% |
| Kreis Leslie W. | director | 2021906 4.8664% | $903,589.79 | 3 | 0 | +5.55% |
| BIOS Memory SPV I, LP | 10 percent owner | 899905 2.1659% | $402,167.54 | 1 | 1 | <0.0001% |
| Wallace Peggy | director | 37961 0.0914% | $16,964.77 | 2 | 0 | <0.0001% |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$992,222,850 | 90 | -12.52% | $19.48M | |
$6,204,522 | 45 | 1.91% | $20.49M | |
$550,024 | 37 | -2.68% | $21.07M | |
$85,897,100 | 36 | 2.47% | $17.37M | |
$217,684 | 34 | 1.61% | $16.13M |
CGTX Institutional Investors: Active Positions
| Increased Positions | 18 | +47.37% | 7M | +179.36% |
| Decreased Positions | 10 | -26.32% | 323,463 | -8.06% |
| New Positions | 7 | New | 7M | New |
| Sold Out Positions | <1 | Sold Out | 11,000 | Sold Out |
| Total Postitions | 46 | +21.05% | 11M | +171.3% |
CGTX Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Bios Capital Management, Lp | $2,682.00 | 14.29% | 6M | +6M | New | 2024-12-31 |
| Vanguard Group Inc | $554.00 | 2.95% | 1.24M | -2,987 | -0.24% | 2024-12-31 |
| Sigma Planning Corp | $275.00 | 1.46% | 614,490 | +417,300 | +211.62% | 2024-12-31 |
| Voss Capital, Lp | $224.00 | 1.19% | 500,000 | +500,000 | New | 2024-12-31 |
| Alyeska Investment Group, L.P. | $224.00 | 1.19% | 500,000 | 0 | 0% | 2024-12-31 |
| Geode Capital Management, Llc | $158.00 | 0.84% | 352,348 | +28,705 | +8.87% | 2024-12-31 |
| Cm Management, Llc | $89.00 | 0.48% | 200,000 | -50,000 | -20% | 2024-12-31 |
| Kestra Advisory Services, Llc | $79.00 | 0.42% | 177,434 | -11,000 | -5.84% | 2024-12-31 |
| Blackrock, Inc. | $70.00 | 0.37% | 156,039 | +494 | +0.32% | 2024-12-31 |
| State Street Corp | $54.00 | 0.29% | 121,850 | +59,100 | +94.18% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
No data is available at this moment.
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.